Do you want to skip to content? Skip to content
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Disrupts, destroys, and prevents biofilm re-formation

1,2

  • Biofilm delays wound healing.4
  • Exudate and slough allow biofilm to develop and thrive.3
  • Bioflim provides tolerance to antimicrobial agents and can result in persistent inflammation and infection.5

To prevent biofilm reformation on wound bed, effective long-lasting antimicrobial protection is needed.6

A green single-eyed slime monster is used to represent biofilm. ;

Hydrofiber™ Technology

Hydrofiber™ Technology forms a cohesive gel that absorbs and retains exudate, inflammatory proteases, debris, microorganisms8 and disrupted biofilm.3

Hydrofiber™ Technology logo, a soft and absorbent material that transforms into a gel on contact with wound fluid. ;

MORE THAN SILVER™

BEC8, a surfactant, reduces the surface tension within a biofilm to enhance the anti-biofilm performance of Aquacel® Ag+ Extra™ dressing.3,5

EDTA9,10, a metal chelating agent, EDTA helps disrupt biofilm by removing metal ions that hold the EPS matrix together to expose microorganisms to the antimicrobial effects of the ionic silver.3,6

IONIC SILVER11,12, a broad-spectrum antimicrobial contained in a safe and effective quantity (1.2%) ensures cell death of the exposed bacteria by damaging the DNA, denaturing proteins and enzymes, and interfering with protein synthesis.2,7

Developing MORE THAN SILVER™ technology involved researching a wide range of biofilm-disrupting agents and surfactants in combination with antimicrobials.2

A circular diagram with sections labelled "EDTA", "IONIC SILVER", and "BEC" describes working together to disrupt biofilms. ;
A smiling face with two hearts inside a circle indicates that 78% of wounds showed improved healing within 4 weeks.

78% of wounds are healed or progressed within 4 weeks.16

Two medical professionals standing side-by-side indicate that 99% of clinicians recommend Aquacel® Ag+ Extra™ dressing.

99% of clinicians would recommend the use of Aquacel® Ag+ Extra™ dressing.16

Indications1

  • Leg ulcers, including:

    - venous stasis ulcers 
    - arterial ulcers 
    - leg ulcers of mixed aetiology
  • Diabetic foot ulcers
  • Pressure ulcers/injuries
  • Surgical wounds
  • Traumatic wounds
  • Malignant wounds
  • Partial thickness burns
Aquacel™ Ag+ Extra and Aquacel™ Ag+ Ribbon Dressing with Hydrofiber™ Technology and Ag+ Technology - a unique ionic silver. ;

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?